Insys Agrees to Pay $4.45 Mln to Resolve Illinois Opioid Lawsuit

12:23 EDT 21 Aug 2017 | Medscape

Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses.
Reuters Health Information

Original Article: Insys Agrees to Pay $4.45 Mln to Resolve Illinois Opioid Lawsuit


More From BioPortfolio on "Insys Agrees to Pay $4.45 Mln to Resolve Illinois Opioid Lawsuit"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...